Literature DB >> 7024336

Pemphigoid nodularis.

C W Yung, K Soltani, A L Lorincz.   

Abstract

We here report the unusual occurrence of bullous pemphigoid mimicking prurigo nodularis in a 59-year-old woman. Direct immunofluorescence studies of a nodular lesion revealed linear deposition of IgG and C3 at the epidermal basement membrane zone (EBMZ). Indirect immunofluorescence studies of serum revealed IgG pemphigoid antibasement membrane zone antibodies in 1:1,280 titer. This entity can be distinguished from other bullous pemphigoid variants.

Entities:  

Mesh：

Year:  1981        PMID： 7024336     DOI： 10.1016/s0190-9622(81)70077-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Bullous pemphigoid: first manifestation under a picture of prurigo simplex subacuta].

Authors:  N Hodzic-Avdagic; G Reinerth; J Reifenberger; R Kruse; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

3.  Vegetating cicatricial pemphigoid. A new subset of the cicatricial pemphigoid spectrum.

Authors:  K Wolff; K Rappersberger; A Steiner; K Konrad
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Persistent Widespread Pruritic Nodules: A Quiz.

Authors:  Hong-Hao Hu; Wen-Jia Yang; Jiu-Hong Li; Hao Guo
Journal:  Acta Derm Venereol       Date:  2021-08-18       Impact factor: 3.875

5.  Juvenile pemphigoid nodularis: Report of a rare case.

Authors:  Dipti Das; Debabrata Bandyopadhyay
Journal:  Indian Dermatol Online J       Date:  2014-04

Review 6.  Case Report: Pemphigoid Nodularis-Five Patients With Many Years of Follow-Up and Review of the Literature.

Authors:  Konrad Szymanski; Alicja Adaszewska; Beata Jakubowska; Cezary Kowalewski; Ewelina Pietrzyk; Katarzyna Wozniak
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.